Skip to main content

Table 1 Characteristics of included studies

From: The impact of provider restrictions on abortion-related outcomes: a synthesis of legal and health evidence

Author/year Country Methods Participants Applicable Provider Restriction
Afework 2015 Ethiopia Individual interviews at three private health facilities Women seeking abortion services n = 38, health extension workers n = 9, healthcare providers n = 7 No provider restrictions in legislation; determined by ministerial guidelines. Elements of CAC may be provided by gynecologists, General Practitioners (GPs), health officers, IESO and nurse midwives, nurses and health extension workers
Andersen 2016 Nepal Program evaluation including baseline and post-training evaluation using provider progress reports and interviews N = 290 primary level facilities providing medical abortion. Interviews with 98 healthcare providers Provision of medical abortion expanded from physicians and staff nurses to auxiliary nurse-midwives already certified as skilled birth attendants
Battistelli 2018 United States Individual interviews Administrators n = 20 whose 5 organizations trained and employed healthcare providers in surgical abortion Provision of first-trimester aspiration abortions extended to nurse practitioners, certified nurse-midwives, and physician assistants
Bridgman-Packer 2018 Ethiopia Case study including a desk review and individual interviews Healthcare providers n = 3, government officials n = 1, NGO staff n = 4 No provider restrictions in legislation; determined by ministerial guidelines. Elements of CAC may be provided by gynecologists, GPs, health officers, IESO and nurse midwives, nurses and health extension workers
De Moel-Mandel 2019 Australia (Victoria) Delphi process Healthcare providers n = 17, experts involved with or interested in medical abortion provision
Of 24 participants 17 completed 3 rounds
Prescription for medication abortion only permitted by physicians who have completed a particular online training program
Grossman 2015 United States and Australia Legal commentary N/A Prescription for mifepristone limited to certified physicians (GPs who have completed online training, or obstetrician-gynecologists exempt from the online training)
Mercier 2015 North Carolina, United States In-depth individual interviews Abortion providers (17 physicians, 9 nurses, 1 physician assistant, 1 counsellor and 3 clinic administrators) Women´s Right to Know Act (WRTK) which mandates that counselling is conducted by licensed medical professionals
Rasmussen 2021 Illinois, United States In-depth interviews 19 primary care clinicians and administrators (7 family physicians, 3 nurse practitioners, 4 certified nurse midwives, 5 administrators) Food and Drug Administration (FDA) Risk Evaluation and Mitigation Strategy (REMS) for mifespristone, which requires providers to be certified with the manufacturer and complete a Prescriber Agreement Form, patients to sign a Patient Agreement Form, and medication to be dispensed only in a clinical, medical office or hospital
Srinivasulu 2021 United States Online qualitative surveys 113 primary care clinicians (67 family physicians, 17 midwives, 12 nurse practitioners or physician assistants, 9 other physician types, 8 no response) Food and Drug Administration (FDA) Risk Evaluation and Mitigation Strategy (REMS) for mifespristone, which requires providers to be certified with the manufacturer and complete a Prescriber Agreement Form, patients to sign a Patient Agreement Form, and medication to be dispensed only in a clinical, medical office or hospital